Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Lung Cancer”

559 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 559 results

Not applicableUnknownNCT03078959
What this trial is testing

Prognostic Value of PD-L1 in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fondazione Ricerca Traslazionale 350
Not applicableStudy completedNCT01883388
What this trial is testing

NovellusDx Cancer Early Detection Blood Test- Clinical Trial

Who this might be right for
Lung Cancer
Fore Biotherapeutics 50
Not applicableUnknownNCT04323579
What this trial is testing

Validation of Multiparametric Models and Circulating and Imaging Biomarkers to Improve Lung Cancer EARLY Detection.

Who this might be right for
Lung Cancer
Istituto Clinico Humanitas 2,000
Not applicableStudy completedNCT01207986
What this trial is testing

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study

Who this might be right for
Hiv InfectionLung Cancer
ANRS, Emerging Infectious Diseases 450
Early research (Phase 1)Looking for participantsNCT06083870
What this trial is testing

An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Lu Shun 35
Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Not applicableEnded earlyNCT03624907
What this trial is testing

Daily vs. Non-Daily SBRT for NSCLC

Who this might be right for
Non-small Cell Lung Cancer
University of Florida 20
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Early research (Phase 1)Looking for participantsNCT03546829
What this trial is testing

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)UnknownNCT04026841
What this trial is testing

The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.

Who this might be right for
Multiple Primary Lung Cancers
The First Affiliated Hospital of Guangzhou Medical University 36
Not applicableLooking for participantsNCT06122077
What this trial is testing

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Who this might be right for
Lung Cancer Diagnosis
Freenome Holdings Inc. 20,000
Not applicableStudy completedNCT02459002
What this trial is testing

Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
M.D. Anderson Cancer Center 209
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Not applicableLooking for participantsNCT06638554
What this trial is testing

Integrating Telehealth to Advance Lung Cancer Screening

Who this might be right for
Early Detection of CancerTelemedicineDecision Making
Abramson Cancer Center at Penn Medicine 6,000
Not applicableStudy completedNCT03892096
What this trial is testing

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CarcinomaMetastatic Colorectal CancerMetastatic Breast Cancer
Cadex Genomics 130
Not applicableUnknownNCT04629079
What this trial is testing

Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care Imaging

Who this might be right for
Lung Cancer
King's College London 800
Not applicableLooking for participantsNCT06632886
What this trial is testing

AI-Assisted Non-Contrast CT for Multi-Cancer Screening

Who this might be right for
Lung CancersLiver CancerGastric Cancers+4 more
Guo ShiWei 1,000,000
Not applicableLooking for participantsNCT06756217
What this trial is testing

68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Ruijin Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05742607
What this trial is testing

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

Who this might be right for
Non Small Cell Lung Cancer
Innate Pharma 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Load More Results